The pathology and clinical features of primary lymphosarcoma and allied tumours of the alimentary tract have been described by several authors, including Spellberg and Zivin (1949) and Skrimshire (1955) . These tumours are uncommon, but may produce dyspepsia, gastrointestinal haemorrhage, or intestinal obstruction. A rare complication is the development of steatorrhoea and overt malabsorption. This was first described by Fairley and Mackie (1937) , and the relevant literature has recently been reviewed by Sleisenger, Almy, and Barr (1953) , who reported four further cases.
In the majority of patients with lymphosarcoma, involvement of the gastrointestinal tract and mesenteric lymph nodes is an incidental pathological finding associated with infiltration of many other tissues. It rarely produces significant symptoms, and is not regarded as important in the natural history of the disease. In a recent patient (As) who underwent splenectomy for acquired haemolytic anaemia associated with lymphosarcoma, we were impressed by th2 appearance of stiffened oedematous bowel at operation, although the patient had noted only slight symptoms of intestinal dysfunction. We therefore decided to investigate intestinal function in an unselected *Adolph Basser Research Fellow in Medicine, Royal Australasian College of Physicians. series of patients with lymphosarcoma not arising primarily in the alimentary tract. Since somewhat similar infiltration of the intestinal wall and mesenteric lymph nodes may also occur in patients with chronic lymphocytic leukaemia, patients with this condition were included in the investigation.
Special emphasis has been given to the folic acid absorption test, as Chanarin, Mollin, and Anderson (1958) reported that injected folic acid was cleared from the plasma more rapidly than normal in some patients with leukaemia and related disorders. These patients had an associated megaloblastic anaemia, and it was considered that the anaemia was due to folic acid deficiency. Proliferating neoplastic cells have greater than normal requirements for folic acid (Swendseid, Bethell, and Bird, 1951) ; however, Chanarin and his colleagues noted that some patients failed to absorb folic acid normally.
The present paper describes in detail the folic acid absorption test used in this laboratory, and reports the results of several intestinal absorption tests in patients with lymphosarcoma and related conditions, comparing these to folic acid absorption and the clinical state of the patient.
Methods
Folic Acid Absorption Test.-The folic acid absorption test was performed as follows.
Preparation of the Subject.-The subjects were loaded with folic acid before the test. This was achieved in normal control individuals by giving 15 mg. folic acid orally on each of the fourth, third. and second days before the test. In patients in whom the absorption of folic acid was to be studied, 15 mg. sodium folate (" folvite," Lederle) was given by subcutaneous injection on each of these days. No folic acid therapy was given the day before the test. Subjects fasted from nine hours before until after the completion of the test. During this time water was allowed; food and liquids other than water may affect serum turbiditv readings and were withheld.
Test Procedure.-Five millilitres of venous blood were withdrawn from the fasting subject and allowed to clot in a sterile tube at 37°C. A solution of sodium folate in 20 ml. of water containing the equivalent of 2 mg. folic acid was then drunk. This solution was prepared from an ampoule of sodium folate containing the equivalent of 15 mg. folic acid/ml. Other Tests Used.-Other tests included radioactive vitamin B12 absorption (Pitney and Stokes, 1958) , xylose absorption (Benson, Culver, Ragland, Jones, Drummey, and Bougas, 1957) , and estimations of faecal fat, serum proteins and plasma carotene by standard methods. Fat balances were estimated by the method of Frazer (1956) . In some patients radiological examination of the stomach and small bowel was also performed. (Maddocks, Ralston, and Weiden, 1960) . This patient had clinical malabsorption and steatorrhoea. The diagnosis was established by peroral suction biopsy of the small bowel. The patient with macroglobulinaemia has been included in this series as this condition is thought by some to represent a variant of lymphosarcoma, although she had no clinical signs of this disease. Details of this patient have been published previously (Pitney, O'Sullivan, and Owen, 1958) .
No patient in any group had clinical or radiological evidence of primary intestinal tumour, although some had palpable masses due to enlarged mesenteric lymph nodes. One patient (Bo) had radiographic appearances suggestive of gastric lymphosarcoma, but these appeared late in his disease, and there were no signs of small bowel infiltration. None of the patients had associated megaloblastic anaemia. They were studied at a random time during the course of their disease, but wherever possible when they were not receiving active treatment. Some had, however, received prior treatment with nitrogen mustard, "chlorambucil," or radiotherapy.
Finally, folic acid absorption tests were also carried out on four patients suffering from extensive metastatic carcinoma of non-alimentary origin. These patients were not studied fully, and are not discussed in detail below.
Results
(1) Folic Acid Absorption Tests.-The results are as follows:
Normal Subjects. -Measurable folic acid activity could be demonstrated in every serum sample obtained from 19 normal adults for three hours after an oral dose of sodium folate containing the equivalent of 2 mg. folic acid. In 17, the peak serum concentration was found at the end of the first hour. In the remaining two subjects, the peak occurred at the second hour. Serum concentrations were falling rapidly by the third hour. but the curves were flatter (Fig. 2) patient with macroglobulinaemia (Wo) had an abnormally high peak serum concentration. It is of interest that she had undergone nephrectomy some years previously. The four patients with disseminated carcinoma all showed peak serum folic acid concentrations within the normal range.
(2) Other Investigations.-Results of the other investigations suggested frequent gastrointestinal involvement in the patients studied.
The serum albumin concentration was below 3.5 g. per 100 ml. in 17 of 19 patients studied, and below 3.0 g. per 100 ml. in 12 of these. All patients with lymphosarcoma had some hypoalbuminaemia, as did five of the seven with chronic lymphocytic leukaemia. No patient in any group revealed hypoglobulinaemia, but increased serum globulin was present in four of eight with lymphosarcoma, and one patient each with chronic lymphocytic leukaemia, Hodgkin's disease, and macroglobulinaemia. This frequent occurrence of hyperglobulinaemia meant that, despite the frequent low serum albumin concentrations, the total serum protein levels were below 6.0 g. per 100 ml. in only six of 19 patients, four of whom were suffering from chronic lymphocytic leukaemia. Statistical analysis showed no significant relation between serum albumin or globulin levels and low peak serum folic acid concentrations, but the association between hypoproteinaemia and diminished folic acid absorption was significant at the 5% level.
Diminished fat absorption was suggested in 13 of 17 patients by low plasma carotene concentrations (less than 70 juLg. per 100 ml.), and biochemical steatorrhoea was shown in seven of 12 by increased faecal fat contents in random faecal specimens. Complete six-day fat balances confirmed steatorrhoea in three of four patients. The patient with a normal fat balance (Mo) was, however, unable to tolerate a diet containing 50 g. fat daily, and this result must therefore be considered equivocal. The three groups of patients did not differ significantly in these results, nor was there significant correlation between either low plasma carotene levels or high faecal fat contents and low peak serum folic acid concentrations.
Xylose absorption tests were performed on 15 patients, and impaired carbohydrate absorption demonstrated in eight. The results showed some differences in the three groups of patients. Only two of six with lymphosarcoma had abnormal xylose absorption tests, while abnormal xylose tests were shown in four of five with chronic lymphocytic leukaemia. There was again no significant correlation between xylose absorption and peak serum folic acid concentrations.
The other investigations may be mentioned briefly. Four Discussion The folic acid absorption test described in this paper differs in some respects from that reported by Chanarin, Anderson, and Mollin (1958) . We consider it important to fast the patient in the strict sense. Even the amount of milk contained in a cup of tea may alter the turbidity of serum as recorded by a nephelometer, and the usual light breakfast containing buttered toast may cause naked-eye turbidity of serum. The inclusion of a preliminary serum blank in the assay of test serum samples allows correction to be made for non-specific turbidity. Chanarin and co-workers used a test dose of crystalline folic acid dissolved in dilute alkali. Folic acid is likely to be precipitated out of this solution in the acid milieu of the gastric contents. "Folvite " appears to be more stable at low pH and is probably absorbed more rapidly. This may explain why 17 of the 19 normal subjects reported in this paper showed peak serum levels after the first hour, whereas the controls of the workers mentioned above showed peaks mostly at the second hour. A 2 mg. dose of folic acid as " folvite " gave similar serum values to those described by Chanarin et al. using a 3 mg. dose of folic acid dissolved in dilute alkali. A 2 mg. oral dose gave more satisfactory curves than a 1 mg. dose (Fig. 2) .
The serum concentration of folic acid in these tests is influenced by the amount of folic acid absorbed from the intestine during the time of testing, the rate of deviation to the tissues and the rate of renal excretion of folic acid. In renal failure delayed excretion of folic acid might be expected and we have found abnormally high peak serum concentrations in patients with uraemia. Patient Ca (Fig. 4) The possibility has been considered that the subnormal folic acid absorption curves observed in this investigation were due to increased tissue requirements for folic acid rather than defective absorption. Pollack, Taylor, and Williams (1942) found higher amounts of folic acid in various types of neoplastic tissue than in the corresponding normal tissue, and Swendseid et al. (1951) found higher concentrations of folic acid in leukaemic leucocytes than in normal white cells. Increased tissue requirements does not seem a satisfactory explanation since the four patients with disseminated carcinoma tested presumably also had increased tissue demands for folic acid but all showed normal absorption curves.
Inadequate loading with folic acid before the absorption tests is an unlikely explanation for the subnormal curves. Urinary excretion of folic acid was measured in two normal subjects who each received injections of 15 mg. folic acid on three successive days. This is the loading procedure used in preparation of patients for the tests. Total three-day urinary excretion values in these normal subjects were 17.9 and 19.3 mg. respectively. Assuming that biliary or intestinal loss of folic acid was not significant, these subjects retained more than one half of the total 45 mg. folic acid injected. The highest concentration of total apparent folic acid activity in the body is stated to be in the liver and the concentration in this organ is normally in the range from 1.3 to 5.8 ug./g. wet tissue (Girdwood, 1952 (Girdwood, , 1953 (Gordon, 1959) might offer an alternative mechanism. We have found that such patients are often improved after intravenous therapy with salt-poor concentrated serum albumin. Weight loss, which is often a prominent feature in both lymphosarcoma and chronic lymphocytic leukaemia, is also common with intestinal malabsorption. The occasional development of megaloblastic anaemia in these patients could be due to malabsorption of folic acid as well as to the increased demands of proliferating neoplastic tissue for folic acid.
